STOCK TITAN

Bridgewater Bancshares Inc Form 4 Filings

BWB NASDAQ

Every Form 4 that Bridgewater Bancshares Inc (BWB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow BWB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BWB filings page.

Rhea-AI Summary

Bridgewater Bancshares Inc. director Jeffrey D. Shellberg reported two transactions in company common stock. On February 2, 2026, he disposed of 1,359 shares at $19.63 per share, and on February 3, 2026 he disposed of 540 shares at $19.54, both coded "F".

After these transactions, Shellberg directly holds 276,025 common shares. He also reports indirect holdings "By Trust" of 355,000 shares, 87,000 shares, and 65,000 shares. Footnotes state he serves as trustee and has voting and investment power over the shares held in each named trust.

Rhea-AI Summary

Bridgewater Bancshares chief operating officer Lisa M. Salazar reported several stock transactions in early February 2026. On February 2, 1,062 shares of common stock were withheld at $19.63 per share, and on February 3, 427 shares were withheld at $19.54 per share, both coded "F" for shares withheld to cover taxes or similar obligations. Also on February 3, she acquired 10,088 shares of common stock in a transaction coded "A" at a stated price of $0, typically reflecting a stock award or similar grant. Following these transactions, Salazar directly owned 40,239 shares of Bridgewater Bancshares common stock.

Rhea-AI Summary

Bridgewater Bancshares Inc. director reports stock acquisition

A director of Bridgewater Bancshares Inc. reported acquiring 1,113 shares of the company’s common stock on 12/31/2025 at a stated price of $0, indicating a grant or similar award rather than an open‑market purchase. Following this transaction, the director beneficially owns 308,113 shares directly and 866,722 shares indirectly through a trust. The indirect holdings are held in the Todd B. Urness Revocable Trust, for which Mr. Urness serves as trustee with sole voting and investment power over the trust’s shares.

Rhea-AI Summary

Bridgewater Bancshares’ chief banking officer reported exercising stock options and increasing direct ownership in the company. On 12/12/2025, the insider exercised options to buy 10,000 shares of Bridgewater Bancshares common stock at a price of $7.47 per share.

After this transaction, the officer beneficially owned 131,231 shares directly, plus 7,500 shares held indirectly through a spouse’s IRA. The filing also shows remaining stock options outstanding at various exercise prices and expiration dates under the company’s 2017 Combined Incentive and Non-Statutory Stock Option Plan.

Rhea-AI Summary

Bridgewater Bancshares’ president and CFO reported changes in his ownership of the company’s common stock.

On 12/10/2025, he exercised 6,000 stock options at $7.47 per share and acquired the same number of shares, and also sold 5,211 shares at a weighted average price of $18.049.

After these transactions, he beneficially owns 105,349 shares directly and 1,000 shares indirectly through a spouse’s IRA, and continues to hold multiple stock option awards.

Rhea-AI Summary

Bridgewater Bancshares director Todd B. Urness filed a Form 4 reporting an internal transfer of 350,478 shares of common stock to the Todd B. Urness Revocable Trust dated May 21, 2024 for no consideration.

Following the December 4, 2025 transaction, he directly held 307,000 shares and indirectly held 866,722 shares as trustee of the revocable trust, where members of his immediate family are beneficiaries. He retains sole voting and investment power over the trust shares and remains the beneficial owner of the securities held by the trust.

Rhea-AI Summary

Bridgewater Bancshares Inc. (BWB) reported an insider equity transaction by its CEO and director. On 11/21/2025, the reporting person exercised options to buy 25,000 shares of common stock at $7.47 per share, coded as an "M" transaction. Following this exercise, the individual beneficially owns 1,189,361 shares directly, plus 1,000 shares in each of two indirect custodial accounts for children.

The filing also lists remaining stock options: an option to buy 25,000 shares at $7.47 expiring 09/30/2027, an option to buy 65,000 shares at $12.92 expiring 12/06/2029, and an option to buy 100,000 shares at $17.50 expiring 02/01/2032, all held directly. Vesting schedules for these grants are set in annual increments under the company’s stock option plans.

Rhea-AI Summary

Bridgewater Bancshares Inc. executive reports stock sale. An executive vice president and chief strategy officer of Bridgewater Bancshares Inc. (ticker BWB) filed a Form 4 disclosing an open-market sale of common stock. On 11/21/2025, the officer sold 5,920 shares of common stock at a price of $17 per share, coded as transaction type "S" for a sale.

After this transaction, the officer reports beneficial ownership of 212,003 shares of Bridgewater Bancshares common stock, held directly. The filing indicates it was made by one reporting person, and is signed by an attorney-in-fact on 11/24/2025.

Rhea-AI Summary

Bridgewater Bancshares Inc. executive reports stock sale and option exercise. The EVP & Chief Strategy Officer of Bridgewater Bancshares Inc. (BWB) reported selling 4,080 shares of common stock on 11/13/2025 at a weighted average price of $17.0402, leaving 199,025 shares beneficially owned afterward. On 11/17/2025, the executive exercised options to buy 18,898 shares at an exercise price of $7.47, increasing direct beneficial ownership to 217,923 shares. The filing also lists remaining stock options with exercise prices of $7.47, $12.92, and $17.50 and various vesting schedules under the company’s equity incentive plans.

Rhea-AI Summary

Bridgewater Bancshares (BWB) disclosed an insider transaction by its EVP & Chief Strategy Officer. On 11/10/2025, the officer sold 8,957 shares of common stock at $16.75 (transaction code S). After the sale, the officer beneficially owned 203,105 shares, held directly.

Rhea-AI Summary

Bridgewater Bancshares (BWB) reported an insider ownership update. Director Todd B. Urness transferred 516,244 shares of common stock to the Todd B. Urness Revocable Trust on 11/10/2025 for $0 under transaction code G. The filing states Mr. Urness is trustee, his immediate family are beneficiaries, and he remains the beneficial owner of the trust-held shares with sole voting and investment power.

Rhea-AI Summary

Bridgewater Bancshares (BWB) disclosed an insider transaction on a Form 4. The company’s CEO and director reported an open‑market sale of 15,561 shares of common stock on 11/05/2025 at a weighted average price of $16.5808.

A footnote states the shares were sold in multiple trades at prices ranging from $16.56 to $16.69. After the sale, the reporting person beneficially owns 1,189,361 shares directly. The filing also lists additional indirect holdings as custodian for a child.

Rhea-AI Summary

Bridgewater Bancshares (BWB) insider transaction: The company’s EVP & Chief Strategy Officer reported a sale of common stock. On 11/05/2025, the officer sold 277 shares at $17 per share (Transaction Code S). Following the sale, the officer beneficially owned 212,062 shares, held directly.

Rhea-AI Summary

Bridgewater Bancshares (BWB) reported an insider transaction by its Chief Operating Officer. On 11/06/2025, the officer sold 2,175 shares of common stock at $16.72 (Transaction Code S). After the sale, the officer directly owns 32,091 shares.

Rhea-AI Summary

Bridgewater Bancshares (BWB) CEO and director reported an open market sale of 9,439 shares of common stock on 10/28/2025.

The sale was executed at a weighted average price of $17.0094, with individual trades ranging from $17.00 to $17.08. Following the transaction, the reporting person beneficially owned 1,204,922 shares directly. The filing also lists additional indirect holdings as custodian for a child in 1,000‑share entries.

The footnote states the seller will provide full trade‑level details upon request.

Rhea-AI Summary

Bridgewater Bancshares (BWB) director reported open‑market purchases of common stock. On 10/24/2025, the director bought 16,530 shares at a weighted average price of $17.4439. On 10/27/2025, the director bought 13,470 shares at a weighted average price of $17.4606.

Following these transactions, the director beneficially owned 30,582 shares directly. An additional 298 shares are held indirectly through Volk Advisory Corp.

Rhea-AI Summary

Bridgewater Bancshares Inc. (BWB) Form 4 shows director Jeffrey D. Shellberg reported transactions dated 10/09/2025. The filing records two Code G transactions affecting common stock: a disposition of 54,882 shares and an acquisition of 54,882 shares, both reported with a $0 price, consistent with transfers under a Rule 10b5-1 or similar plan. After the reported activity, Mr. Shellberg directly beneficially owned 289,613 shares and indirectly beneficially owned 372,272 shares through three trusts (holding 87,000, 65,000 and 220,272 implied) for which he has voting and investment power as trustee. The form is signed by an attorney-in-fact on 10/10/2025.

Rhea-AI Summary

Bridgewater Bancshares Inc. director Lawal Mohammed purchased 1,164 shares of common stock on 09/30/2025 at no stated price, increasing his beneficial ownership to 33,280 shares. The Form 4 was signed on 10/01/2025 by an attorney-in-fact. No derivative transactions or additional details were reported.

Rhea-AI Summary

Lisa Brezonik, a director of Bridgewater Bancshares Inc (BWB), reported a non-derivative purchase of 1,164 shares of common stock on 09/30/2025. The transaction was recorded at a price of $0 and brings her total reported beneficial ownership to 33,960 shares. The Form 4 filing is signed by an attorney-in-fact on 10/01/2025.

Rhea-AI Summary

Bridgewater Bancshares Inc (BWB) director Thomas P. Trutna reported a non-derivative acquisition of company stock on 09/30/2025. The Form 4 shows an acquisition of 582 shares with a reported price of $0, resulting in 95,078 shares beneficially owned directly after the transaction. The filing was executed by an attorney-in-fact, Ben Klocke, and dated 10/01/2025.

This disclosure identifies the reporting person as a director and indicates the Form 4 was filed by one reporting person. No derivative transactions or additional explanatory detail are included in the form.

Rhea-AI Summary

James S. Johnson, a director of Bridgewater Bancshares Inc (BWB), reported an acquisition of 1,164 shares of the company's common stock on 09/30/2025. The Form 4 shows 98,947 shares beneficially owned following the reported transaction on a direct basis. The filing also discloses indirect holdings of 59,250 shares held by the James S. Johnson Trust, 76,750 shares held by the Jolynn Johnson Trust, and 10,417 shares held in a spouse IRA, with shared voting and investment power noted for the trusts. The transaction is recorded at a price of $0 on the form. The form is signed by Ben Klocke, Attorney-in-Fact, dated 10/01/2025.

Rhea-AI Summary

Bridgewater Bancshares Inc (BWB) director Todd B. Urness reported an open-market purchase of 1,164 shares on 09/30/2025 at no reported cash price, bringing his total beneficial ownership to 1,173,722 shares. The filing was signed by an attorney-in-fact on 10/01/2025. The transaction is recorded on a Form 4 and reflects a director-level acquisition disclosed under Section 16.

Rhea-AI Summary

David B. Juran, a director of Bridgewater Bancshares Inc (BWB), reported a non‑derivative acquisition of 1,164 shares of common stock on 09/30/2025 at a reported price of $0. After the transaction he is shown as beneficially owning 1,346,708 shares directly and holds additional indirect interests through multiple trusts: 10,725, 95,307, 16,328, and 121,301 shares under various trustee or attorney‑in‑fact arrangements. The filing clarifies the nature of each indirect holding and lists an attorney‑in‑fact signature dated 10/01/2025.